May 27, 2026 04:05PM
May 12, 2026 04:05PM
May 11, 2026 04:05PM
Apr 17, 2026 04:05PM
Apr 15, 2026 04:05PM
Apr 15, 2026 04:05PM
Apr 7, 2026 08:08AM Savara receives UK regulatory acceptance for rare lung disease drug
Apr 7, 2026 08:05AM
Mar 31, 2026 04:27AM
Mar 30, 2026 08:05AM
Mar 30, 2026 08:05AM
Mar 16, 2026 11:22AM
Mar 13, 2026 08:06AM
Mar 13, 2026 08:05AM Savara Reports Fourth Quarter and Year End 2025 Financial Results and Provides Business Update
Mar 6, 2026 04:05PM
Mar 6, 2026 04:05PM
Mar 4, 2026 04:05PM
Feb 23, 2026 04:58AM
Feb 20, 2026 04:15PM
Feb 20, 2026 04:15PM
Feb 13, 2026 04:05PM Savara Announces New Employment Inducement Grant
Feb 4, 2026 04:05PM
Jan 27, 2026 08:06AM
Jan 27, 2026 08:05AM
Jan 16, 2026 04:05PM
Jan 8, 2026 04:05PM
Dec 23, 2025 06:46AM
Dec 22, 2025 08:31AM Savara resubmits drug application to FDA with new manufacturer
Dec 22, 2025 08:30AM
Dec 17, 2025 08:05AM
Dec 11, 2025 08:05AM
Dec 11, 2025 08:05AM
Dec 2, 2025 08:06AM
Dec 2, 2025 08:05AM
Nov 20, 2025 04:05PM Savara Announces Participation in Upcoming Investor Healthcare Conferences
Nov 12, 2025 04:05PM
Nov 3, 2025 04:05PM
Oct 31, 2025 04:05PM
Oct 31, 2025 04:05PM
Oct 29, 2025 09:43PM
Oct 29, 2025 09:43PM
Oct 29, 2025 04:07PM Savara launches public offering of common stock and pre-funded warrants
Oct 29, 2025 04:07PM
Oct 29, 2025 04:01PM
Oct 29, 2025 04:01PM
Oct 17, 2025 08:05AM
Oct 17, 2025 08:05AM
Sep 11, 2025 08:14AM
Sep 9, 2025 06:56AM Savara (SVRA) PT Raised to $11 at Guggenheim
Sep 2, 2025 09:01AM

322,090 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All